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Background: Autism and schizophrenia spectrum disorders both represent severely
disabling neurodevelopmental disorders with marked impairments in social functioning.
Despite an increased incidence of psychosis in autism, and substantial overlap in
symptoms and cognitive markers, it is unclear whether such phenotypes are
specifically related to risk for psychosis or perhaps reflect more general, idiosyncratic
autism traits. The attenuated psychosis syndrome (APS) is primarily defined by the
presence of attenuated psychotic symptoms, which currently constitute the best and
most-replicated clinical predictors of psychosis, and are common in clinical youth with and
without autism. The aims of this study were to test the hypothesis that facial affect
processing is impaired in adolescents with APS and to explore whether such deficits are
more indicative of psychotic or autistic phenotypes on a categorical and dimensional level.
Materials and Method: Fifty-three adolescents with APS and 81 typically developing
controls (aged 12–18) were included. The APS group consisted of adolescents with (n =
21) and without (n = 32) a diagnosis of autism spectrum disorder. Facial affect recognition
was assessed with the Amsterdam Neuropsychological Tasks using a cascade model of
cognitive processing, in which disturbances in “lower-level” cognitive abilities (pattern
recognition), affect “higher-level” cognitive processes (face recognition and facial affect
recognition). For associations with schizotypal and autistic-like traits the Schizotypal
Personality Questionnaire and Social Communication Questionnaire were used in a
confirmatory item factor analysis framework.
Results: Contrary to expectation, APS in adolescents was not associated with
impairments in pattern, face, or facial affect recognition. However, the APS group with
autism spectrum disorder showed a general latency in response time to social and non-
social stimuli. Dimensionally assessed schizotypal and autistic-like traits did not predict the
accuracy or the speed of face or facial affect recognition.
Conclusion: Facial affect processing performance was not associated with APS in
adolescence and represents an unlikely early vulnerability marker for psychosis. APSg August 2020 | Volume 11 | Article 7591
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Frontiers in Psychiatry | www.frontiersin.orindividuals with a more autistic-like profile were characterized by slower responses to
social- and non-social stimuli, suggesting that the combined effect of APS and autism
spectrum disorder on cognition is larger than for APS alone.Keywords: autism spectrum disorder, psychosis, schizophrenia, ultra-high risk, social cognition, emotion
perception, attenuated positive symptomsINTRODUCTION
Autism spectrum disorder (ASD) and schizophrenia spectrum
disorders (SSD) both represent severe ly disabl ing
neurodevelopmental disorders with marked impairments in
social functioning. ASD and SSD co-occur more often than
would be expected by chance (1, 2), and have been found to
share both phenotypic similarities as well as multiple risk factors
(3). Recently, more parallels between ASD and SSD have come to
light, such as overlapping genetic mechanisms and brain
developmental trajectories (4–6). Furthermore, studies are
increasingly focussing on dimensional rather than categorical
approaches, with the aim of testing the hypothesis that both
conditions represent extremes on an extended continuum of
symptomatic severity. These efforts provide evidence for elevated
rates of autistic traits in individuals diagnosed with SSD, and also
report that these traits negatively affect clinical outcome such as
quality of life and global functioning (3, 7–10)
Of interest for the present study is the striking overlap of many
cognitive traits between ASD and SSD (11), especially within the
domain of social cognition (8, 12–15). For example, investigations
of emotion recognition in both ASD and SSD reveal consistent
impairments compared to healthy controls (13, 16). However, in
a recent direct comparison of substantial clinical samples, adults
with ASD seemed significantly more impaired than adults with
SSD in emotion perception from faces (15). Although this
difference may become less pronounced with increasing age due
to progressive cognitive deterioration in SSD (12), cross-sectional
studies show that clear social cognitive impairments are already
present at first onset of psychosis (17, 18). In addition, numerous
studies have reported social cognitive deficits in individuals at risk
for psychosis, that is, in both first-degree relatives of
schizophrenia patients (19), as well as in individuals with a
clinical or “ultra” high risk (UHR) for psychosis (20). However,
it remains unclear as to how and when these impairments develop
(21) and whether they convey a similar risk for psychosis in UHR
and ASD.
The UHR criteria were developed to help identify young help-
seeking individuals at imminent risk for developing a psychotic
disorder (22). In the past decades it has been established that
approximately 20% of UHR positive individuals will develop a
psychotic disorder within two years of identification (23),
depending on the study population base rate and type of
inclusion criteria (24). Also, transition rates have been slowly
declining over time (25) and tend to be somewhat lower in young
adolescent UHR populations (26, 27), though they remain
staggeringly high compared to the general population. Of the
different UHR inclusion criteria, attenuated positive symptoms areg 2by far the most commonly represented and currently constitute
the best and most-replicated clinical predictors of psychosis (28).
Together with the proposal to include an attenuated psychosis
syndrome (APS), which is almost exclusively defined by the
presence of attenuated positive symptoms, into the DSM (29),
this has led to a partial shift in research focus toward (presumably)
more homogenous APS samples to improve replicability of factors
associated with risk for psychosis.
Like APS, a childhood diagnosis of ASD is also characterized
by much greater odds to develop psychosis compared to the
general population (2, 30). Psychotic symptoms are not included
in diagnostic ASD criteria, yet many individuals diagnosed with
ASD report psychotic symptoms, even at a young age (31–34).
Given the elevated risk for psychosis in young people with APS
and ASD, as well as the shared phenomenology, direct
comparisons between the two are notably absent from the
literature. As an exception, a recent longitudinal study reported
that UHR patients with and without premorbid ASD showed
similar APS at baseline and conversion rates to full-blown
psychosis for both groups (35). However, baseline social
cognitive performance (i.e. social perception and theory of
mind) was more affected in UHR with ASD. This suggests
that social cognitive deficits contain a different level of risk
for transition to psychosis in UHR individuals with and
without ASD.
As highlighted above, social cognition deficits are commonly
proposed as a potential early vulnerability marker for
psychosis. However, actual associations with transition to
psychosis are few and inconsistent in high-risk research (36).
Regardless, some studies suggest a positive predictive value of
specific impairments in facial affect processing for the transition
to psychosis (37–39) and negative outcomes (40), which
warrants further investigation. Facial affect processing is
associated with non-affective facial processing and, in addition
to involvement of the limbic regions, partially requires activation
of the same cortical structures, such as the fusiform face area
(41). In turn, non-affective facial processing involves similar
brain regions as non-affective visuospatial processing, i.e. the
processing of patterns or objects, but evokes differential
activity patterns (42). In this view, more complex and “higher-
level” social cognitive skills such as facial affect processing and
non-affective facial identity recognition may partially rely on
“lower-level”, non-social visual processing skills for optimal
functioning, which is often reported as being aberrant in
schizophrenia (43–45). Simultaneous assessment of these three
separate, yet interrelated, levels of visual processing can therefore
further inform us on their associations with psychotic and/or
autistic behavior.August 2020 | Volume 11 | Article 759
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help-seeking adolescents (12–18 years) suffering from APS with
and without ASD and to explore whether any deficits are more
indicative of psychotic or autistic phenotypes on a categorical and
dimensional level. Furthermore, facial affect recognition was
assessed within the context of a cascade model of cognitive
processing, in which disturbances in “lower-level” cognitive
abilities (pattern recognition), affect “higher-level” cognitive
processes (facial identity and facial affect recognition). Previous
studies using the same cognitive paradigms have indicated
that facial affect recognition was most impaired in chronic
schizophrenia compared to controls (46) and that disadvantages
in facial recognition was a typical feature in children with ASD (47,
48). However, direct comparisons of APS adolescents with and
without ASD have not been investigated previously. Based on
findings described above, we hypothesized that: 1) facial affect
processing would be affected in young adolescents with APS in
general, but more strongly related to autism than psychosis on
both a categorical and dimensional level; 2) a negative association
exists between autistic features and face recognition; and 3) pattern
recognition ability would have a stronger, negative impact on
facial (affect) recognition in APS without ASD, compared to those
with ASD and controls.MATERIALS AND METHODS
Participants
The study was conducted at the Child and Adolescent Psychiatry
Department of the University Medical Center Utrecht. This
subsample of the Dutch Prediction of Psychosis Study recruited
adolescents (aged 12–18 at intake; M = 15.26, SD = 1.73) putatively
at UHR for psychosis. All patient participants were referred help-
seekers. Having APS was defined as meeting the Attenuated Positive
Symptom Psychosis-Risk Syndrome, as defined in the Criteria of
Psychosis-risk Syndromes of the Structured Interview for
Prodromal Syndromes (SIPS version 3.0; 49). To fulfil these
criteria a patient must receive a rating of level “3”, “4”, or “5” on
at least one of the P1-P5 positive symptom items. Having a
prepubertal clinical diagnosis of ASD was obtained from
information present in the medical records and was confirmed by
expert clinical opinion after psychiatric examination including the
Autism Diagnostic Interview—Revised (50). The APS groups
without and with ASD are from here on referred to as APS/ASD
− and APS/ASD+, respectively. Typically developing controls were
recruited by distributing information brochures about the research
project at several secondary schools in the region of Utrecht. They
were excluded if they or a first degree relative had a history of any
psychiatric illness, or if they had a second degree relative with a
history of a psychotic disorder, as determined by using the Family
Interview for Genetic Studies (51). The control group was also
screened using the SIPS and individuals were excluded if they met
APS criteria. All participants signed an informed consent, and for
those younger than 16, the primary caretaker(s) co-signed. The
study was approved by the Dutch Central Committee on Research
Involving Human Subjects.Frontiers in Psychiatry | www.frontiersin.org 3Schizotypal and Autistic Traits
The Schizotypal Personality Questionnaire [SPQ; (52)] is a self-
report instrument for assessing trait levels of psychotic-like
experiences. It consists of 74 “yes/no” statements addressing
the Cognitive-Perceptual Deficits, Interpersonal Deficits, and
Disorganization subtraits. This postulated structure of three
highly correlated traits has been found to describe clinical data
well (53).
The Social Communication Questionnaire (SCQ),
previously known as the Autism Screening Questionnaire
(54), is a parent-report instrument which addresses autistic
traits over the lifetime. Of the 40 “yes/no” questions, all items
except 3–8 are scored as reversed. Item 1 was deleted as it is the
verbal ability screen for items 2–7, and items 2–7 were deleted
for the two cases who responded “no” to item 1. The SCQ has
recently been reported to measure three subdimensions of
autistic behaviour, namely the Social, Rigidity, and Non-
Verbal Communication subtraits, of which the former is
moderately correlated with the two latter (55). Like Martin et
al. (55), we found items 24 and 25 to have an extremely high
tetrachoric sample correlation, but item 25 was retained and
assigned to Non-Verbal Communication. Due to the low levels
of autistic traits in healthy controls, the parents of that group of
participants were not asked to fill in this questionnaire.
Cognitive Paradigms
Facial affect recognition, face recognition, as well as “lower-level”
cognitive skills, namely pattern recognition, were assessed with
the Amsterdam Neuropsychological Tasks (ANT), version 2.1
(56). The ANT is a computerized neuropsychological test battery
and has proved to be a reliable and valid instrument. Three
modules of the ANT were administered for the purpose of this
study, namely 1) Feature Identification (FI); 2) Face Recognition
(FR); and 3) Identification of Facial Emotions (IFE). The tasks
will be described in detail below, for visual representations of the
paradigms we refer to Barkhof et al. (46).
The Feature Identification (FI) task consists of 40 trials (20
each of easy and hard conditions) of recognizing a briefly seen
target pattern of red and white squares in a subsequently
presented 2-by-2 matrix of potential matches. Participants
were asked to determine whether the target pattern was
present in the 2-by-2 matrix by pressing either YES (target
present) or NO (target not present). The target pattern was
presented only at the beginning of the task, and had to be kept in
mind during the whole task. There were an equal number of
target and lure trials, presented in a standard pseudorandom
order. Face Recognition (FR) was otherwise similar, but used face
stimuli. Participants had to determine whether a target face was
present in a set of four, subsequently shown faces. Again, there
were 40 trials, half of which required a YES response, and half of
which required a NO response, presented in a random order.
Identification of Facial Emotions (IFE) also used the same
general setup, but the participant was required to determine
whether a target emotion was expressed by a succession of faces
that could express any of the following eight emotions:
happiness, sadness, anger, fear, disgust, surprise, shame, andAugust 2020 | Volume 11 | Article 759
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each emotion, but only the first four parts were used in the
present study, namely happiness, sadness, anger and fear. Each
part consisted of 40 trials, half of which were faces that expressed
the target emotion (requiring a YES response), and half of which
are faces that expressed a random selection of the other seven
emotions (requiring a NO response). All trials were analysed
jointly for both accuracy as well as speed as a single task.
Individual task results with an error rate of 40% or greater
were discarded (one task of one participant in each group), as
were those where the task administrator determined that the
respondent was confused regarding the instructions (all tasks of
one participant in the ASD group). To correct for individual
response bias tendencies, the signal detection theory (SDT)
discriminability index d’ was used as the measure of accuracy.
To make error-free accuracy possible to score as d’, the loglinear
transformation rule was applied throughout, as recommended by
Hautus (57). In addition to accuracy, response times for correct
responses were recorded as a measure of performance. Since
response times had skewed distributions, these were converted to
response speed (responses per second), which normalized
distributions in each group.
Performance in the non-social FI task was used primarily as a
baseline for separating the face-specific component of the FR and
IFE tasks from its more general visual memory and
task performance.
Statistical Analyses
To assess whether questionnaire responses were sufficiently one-
dimensional to use as indicators of single underlying constructs,
the included items of the clinical scales were used as categorical
indicators of their respective latent variables in separate
confirmatory item factor analyses (IFA) using the WLSMV
estimator in Mplus 8.3 (58); each item was assigned to a single
factor, but all threshold, loading, and factor correlation
parameters were freely estimated. Model fit was assessed with
the Comparative Fit Index (CFI), the Root Mean Square Error of
Approximation (RMSEA), and explained common variance
(ECV). Further analyses used the maximum a posteriori factor
scores derived from these factor analyses. Confirmatory IFA
analyses of the published three-dimensional structures were
done in a similar manner.
As cognitive task performance was somewhat dependent on age
and gender in the control group, all accuracy and speed analyses
used standardized regression residuals of d’ or response speed, that
is, the difference between the individual’s observed score and the
expected score in the control group for that age and gender. In
analyses additionally controlling for FI, the performance on that
task was entered as a covariate in the regressions along with age and
gender. All analyses additionally controlling for FI use the same data
(accuracy/accuracy, and speed/speed).
For group comparisons on the trait and cognitive measures
we used U tests (as most data was non-normally distributed, and
at a conservative p < 0.01 due to the number of tests) and
reported the corresponding non-parametric effect size A (59),
which is equivalent to the Area Under the Curve of SDT, and can
be estimated with the formula (n1n2 − U)/n1n2 (60). In Cohen’sFrontiers in Psychiatry | www.frontiersin.org 4(61) terminology an effect size A = 0.57 (~ d = 0.2) can be
considered small, an effect size A = 0.64 (~ d = 0.5) can
be considered medium and an effect size A = 0.71(~ d = 0.8)
can be considered large. All analyses except the IFAs were done
in IBM SPSS Statistics 26.0. In the primary linear dependence
regression analyses, accuracy and response speed were predicted
in separate forward-stepping linear regressions by the latent
factor scores of the two trait dimensions (SPQ and SCQ). In
the similar secondary and exploratory analyses, the predictors
were the SPQ and SCQ subdimension factor scores.RESULTS
Subgroup Characteristics
A total of 66 patient participants and 81 healthy controls
contributed partial or complete data. Of the patients, 53 had
both clinical and cognitive data available, and fulfilled APS
criteria, forming the patient subsample for the main analyses.
In addition to meeting APS criteria, six patients also met brief,
limited, or intermittent psychotic symptoms (BLIPS) criteria as
assessed by the SIPS, and three patients also met criteria for
genetic risk of psychosis and deterioration (GRD). The patient
subsample consisted of adolescents with (n = 21; APS/ASD+
group) and without (n = 32; APS/ASD− group) a diagnosis of
ASD. Group characteristics are reported in Table 1. APS/ASD−
patients were significantly older than APS/ASD+ patients and
healthy controls. Both patient groups had somewhat lower IQs
than healthy controls. Both APS/ASD− and APS/ASD+ patients
showed higher SPQ scores than healthy controls, with no
significant difference in SPQ scores between the two patient
groups. As expected, the APS/ASD+ group had higher scores on
SCQ than the APS/ASD− group.
Data Quality
Age, cognitive variables, and latent psychopathological factors
were approximately multivariate normal, and linear regression
between them was thus appropriate. The few missing values were
treated as being missing at random and all analyses were
performed with all available values. The fit of the SPQ and
SCQ in unidimensional factor analyses was acceptable (CFI.90/
.89, RMSEA.04/.05, with 44%/41% mean explained variance,
respectively), and the fit of the three-dimensional models was
good (CFI . 96 / . 94 , RMSEA.03 / . 04 , w i th 54%/52%
explained variance).
Latent factor scores on the two clinical SPQ and SCQ
measures were weakly negatively associated with each other
among the patients, Pearson r = −0.17 (p = 0.25), only the
SCQ was predicted by age, r = −0. 37 (p = 0.01), and there was a
trend towards girls having higher SPQ factor scores,
A = 0.67 (U = 204).Cognitive Group Comparisons
The cognitive group comparisons are described in Table 1 and
summarized below. Firstly, there was no significant difference
between the three groups (APS/ASD− vs. APS/ASD+ vs.August 2020 | Volume 11 | Article 759
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ASD+ patients were slower in their responses on the FI task than
the APS/ASD− and the control groups (Figure 1). Secondly,
there was no significant difference between the three groups
(APS/ASD− vs. APS/ASD+ vs. Controls) in accuracy on the FR
task. Again, the APS/ASD+ patients were slower than the other
groups (Figure 1). However, this difference did not remain
significant after controlling for response speed on the “lower-
level” FI task. Lastly, no significant group differences were found
for the IFE task with respect to either accuracy or response speed.
The APS/ASD+ group was again slower in responding than the
APS/ASD− group and controls with medium effect sizes, but this
difference was not statistically significant.
Linear Prediction of Social Cognition With
Clinical Features
The only cognitive variable which was predicted by SCQ or SPQ
factor scores was Feature Identification (FI) accuracy, which was
predicted by the SPQ (b = 0.37). Secondary analysis revealed that the
subfactor Disorganization sufficed to account for this effect (b = 0.37).DISCUSSION
The aim of this study was to test the hypothesis that facial affect
processing is impaired in young adolescents with APS, and
whether visual processing at different cognitive levels could
help differentiate between those with and without a
prepubertal diagnosis of ASD. Neither of the APS groups
displayed generalized impairments in the accuracy of facial
affect recognition, nor in face or pattern recognition, indicating
that these cognitive skills may have limited use as early psychosis
vulnerability markers in APS. However, the APS group with ASD
generally showed slower responses for affective and non-affective
face stimuli than APS participants without ASD and healthy
controls, which was fully explained by a slower response time on
“lower-level” feature identification.
Contrasting previous findings in UHR samples (62–65), we
did not find general emotion processing deficits in the APS
groups compared to healthy controls. Given that most
individuals with UHR would also qualify for APS, it is unlikely
that this stark contrast is due to the inclusion of a more
homogenous subset of individuals putatively at-risk.
Furthermore, it is undisputed that psychotic conditions are
characterized by deficits in facial affect processing (41, 66), but
the questions of how and when these deficits manifest remain
unresolved so far. A possible explanation of why deviations were
not detected in our sample, could be that the number of “false
positives” (APS individuals who never convert to psychosis) was
too high to be able to discriminate between the APS groups and
healthy controls, or perhaps cognitive deterioration only occurs
closer to the onset of frank psychosis. Alternatively, facial affect
processing difficulties may not emerge until a later age, provided
that the involvement of crucial brain structures, such as the
amygdala, are still undergoing developmental changes during
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Maat et al. Affect Processing in Attenuated PsychosisFinally, due to limited clinical sample sizes, we applied a
conservative statistical approach and did not test for emotion-
specific variables. There is evidence that facial affect deficits may
be more specific in at-risk individuals, e.g. the mislabelling of
positive/neutral expressions (37, 40, 69)
Surprisingly, we did not find categorical or dimensional
associations with facial emotion or face recognition accuracy in
APS with and without ASD. The largest meta-analysis to date
directly comparing emotion perception from faces between ASD
and SSD subjects reported that both patient groups are impaired
and that ASD subjects are significantly more impaired than SSD
patients. However, this difference disappears with increasing age
(12). The authors suggest that this may reflect a deterioration of
social cognitive skills in SSD patients with increasing age, or an
age-dependent improvement of emotion perception skills in
ASD as a result of social learning. The fact that the APS group
without ASD was significantly older in our study could therefore
partially explain the negative findings for facial affect
recognition. However, we did account for age in our analyses
by using standardized regression residuals. Equally striking is the
lack of a hypothesized negative relation between face recognition
and autistic traits, which has previously been described for this
task in ASD populations (47, 48). Together these findings are
more in line with the general notion that social cognitive
performance in psychosis and ASD are perhaps more similar
than dissimilar (15, 70) and teasing this apart may require more
refined paradigms, for example by using more ecologically valid
stimuli, such as dynamic faces, and by combining them with
methods with high temporal resolution, such as EEG or eye-
tracking. These commonly available approaches are only just
starting to be utilized for direct group comparisons between
individuals with ASD and SSD (71–73).
Regarding our third and final hypothesis, no evidence was
detected that could indicate basic visual processing may have a
stronger, negative impact on facial (affect) recognition in APS
without ASD. We did observe a trend towards a significant
difference in accuracy, but results were pointing in the opposite
direction, i.e. relatively better performance in APS without ASD,
and even more so when corrected for pattern recognition. This
finding appears to be at odds with common notions of early
visual processing difficulties in schizophrenia research (43, 44)Frontiers in Psychiatry | www.frontiersin.org 6and recently also in UHR individuals (39). In contrast to APS
individuals without ASD, those with ASD showed slower speed
of processing on all cognitive tasks in lieu of typical accuracy.
This in line with the notion that it may take more time to process
faces in autism, except evidence for this has been inconsistent in
ASD (74, 75) and here it appeared to be explained by a more
general delay in processing speed, and not by the increased
complexity of social stimuli. However, together these findings do
suggest that studying the relative impact of psychotic or autistic
traits on facial affect processing may benefit from taking into
account the individual trade-off between speed and accuracy.
Future studies are encouraged to also include a group of ASD
individuals without APS to address this issue more thoroughly.
An important limitation of this study is that the use of
psychotropic medication was not an exclusion criterion for the
psychosis-risk groups, and that the effects of different types of
medication on neurocognitive performance are still poorly
understood. Secondly, it is possible that the group differences
in the present study did not reach statistical significance, because
the sample sizes were relatively small. Thirdly, the number of
psychotic transitions in this particular APS sample are reportedly
low (data available for 10 or less transitions) (27, 76, 77) and
could suggest our sample was not highly representative of UHR/
APS samples with higher transition rates.
To conclude, this study demonstrated that traditional
computerized assessment of facial affect processing is unlikely
to detect early vulnerability markers for psychosis in adolescents
with APS. A more autistic-like APS profile may be characterized
by a generalized increase in response latencies, suggesting that
the combined presence of autistic and psychotic traits may
disproportionately affect cognitive performance. However, this
needs to be replicated with more realistic and dynamic social
cognitive stimuli, and supplemented by taking into account
speed-accuracy trade-offs. The majority of intervention studies
in patients at risk for psychosis focus on a variety of cognitive
behavioural therapies for treatment of APS, but until now no
specific intervention has been designed for the ASD group (78).
Given the elevated risk for psychosis in ASD and our current
inability to sufficiently discern between cognitive features in both
conditions, there is dire need for more comparative studies to
help inform personal treatment guidelines.FIGURE 1 | Response times (RT; standardized residuals of responses per second, corrected for sex and age) plotted by group for all three cognitive tasks. Dots
represent individual averages with higher scores reflecting faster response times. The summary of the data is shown as a boxplot, with the box indicating the
interquartile range (IQR), the whiskers showing the range of values that are within 1.5*IQR and the horizontal line indicating the median. *p <.01; **p <.001.August 2020 | Volume 11 | Article 759
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